{
  "docId": "019de06f-55b4-734a-a2e3-c1019ed629b5",
  "docSlug": "42b17c6fff3e2006bf9fc5d84bd6edcc",
  "documentTitle": "Pershing Square | Activist Presentation Deck | 120 slides",
  "authorId": "pershing-square",
  "authorName": "Pershing Square Capital Management, L.P.",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2014-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2955465,
  "pageNumber": 31,
  "pageCount": 120,
  "prevPage": 30,
  "nextPage": 32,
  "slideType": "timeline",
  "function": "establish_context",
  "density": "overcrowded",
  "nDataPoints": 5,
  "notes": "The slide uses a red dashed box to highlight the May 30th offer, likely to emphasize the peak of the bidding war or a specific turning point.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de06f-55b4-734a-a2e3-c1019ed629b5/31",
  "deckHref": "/decks/019de06f-55b4-734a-a2e3-c1019ed629b5",
  "deckJsonHref": "/decks/019de06f-55b4-734a-a2e3-c1019ed629b5.json",
  "deckAnchorHref": "/decks/019de06f-55b4-734a-a2e3-c1019ed629b5#slide-31",
  "components": [
    {
      "bbox": {
        "h": 0.07,
        "w": 0.92,
        "x": 0.04,
        "y": 0.78
      },
      "kind": "callout",
      "text": "Pershing Square is Allergan's largest investor with 9.7% ownership",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "08c27709-3d8d-4cca-ad41-2a98e157e049",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.81,
        "x": 0.11,
        "y": 0.58
      },
      "kind": "list",
      "text": "Valued at Valeant's current share price, the current offer implies a ~50%+ premium to Allergan's unaffected trading price and 23x+ EBITDA multiple",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "015b7a57-46c5-4586-987c-e29f87983eb7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.81,
        "x": 0.11,
        "y": 0.37
      },
      "kind": "list",
      "text": "Allergan publishes subsequent presentations on June 10th and July 14th",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5fa6f878-5bdf-4832-9780-f9aecd3d15a4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.85,
        "x": 0.07,
        "y": 0.49
      },
      "kind": "list",
      "text": "On May 30th, in response to investor feedback, Valeant raises cash component of the offer to $72.00 per share and commits to not raise offer again without substantial engagement from Allergan",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "099d1035-8b02-4cf5-8337-7cfa6cb186cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.85,
        "x": 0.07,
        "y": 0.3
      },
      "kind": "list",
      "text": "On May 27th, Allergan publishes presentation attacking Valeant's business model and management team",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e726e2b-b423-478e-be4e-c51d2d767c44",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.85,
        "x": 0.07,
        "y": 0.26
      },
      "kind": "list",
      "text": "On May 12th, Allergan rejects initial Valeant offer",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "328668f6-09be-4818-ba8f-ae86ffa7ab3e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.85,
        "x": 0.07,
        "y": 0.66
      },
      "kind": "list",
      "text": "On June 23rd, Allergan's unanimously rejects Valeant's revised bid and describes the bid as \"grossly inadequate\"",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4618cfcd-c4bd-4365-9103-c773f85df67b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.85,
        "x": 0.07,
        "y": 0.19
      },
      "kind": "list",
      "text": "On April 22nd, Valeant announces initial offer to acquire Allergan for 0.83 Valeant shares and $48.30 per share in cash",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "46ba4916-890d-4bcd-b7c0-d26591c646bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.85,
        "x": 0.07,
        "y": 0.41
      },
      "kind": "list",
      "text": "On May 28th, Valeant raises cash component of offer to $58.30 per share plus a contingent value right for DARPin",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bf80ee57-0fdb-441e-bc2c-ca4af62d0372",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.35,
        "x": 0.04,
        "y": 0.07
      },
      "kind": "title",
      "text": "History of the Transaction",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a658b1c-82f4-4560-b084-815fa63bf9f1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "2a4f2bda-75ec-46ac-aff5-5a9a33f852ed",
      "evidence": "Chronological list of events",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 40,
      "from": 31,
      "name": "Iceberg",
      "slug": "10-iceberg",
      "bestFor": "Consulting, complex problem solving, organizational change",
      "matchId": "8bf64e6f-6eda-40f4-bfec-81e388dad58f",
      "evidence": "The document provides detailed financial analysis to support the valuation of the deal",
      "position": 0,
      "objective": "To reveal the true value of the deal",
      "structure": "The Symptom (Visible) -> The System (Hidden) -> The Root Cause",
      "confidence": 0.8,
      "description": "Reveal that the visible problem is merely a symptom of a deeper root cause"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}